New Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe

Business Wire2022-11-03

Analysis shows greater pharmacist prescribing authority dramatically improves patient access SANTA MONICA, Calif., November 03, 2022--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), a leading consumer-focused...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2280759672?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/t4NpyJ6yFG_Wieah4aUzGA--~B/aD0xMDI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a74e7f0783b8340941d5d8dfc940b160","is_english":true,"pubTime":"2022-11-03 19:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2280759672","market":"us","top_or_hot":-1,"title":"New Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe","media":"Business Wire","content":"<div>\n<p>Analysis shows greater pharmacist prescribing authority dramatically improves patient access\nSANTA MONICA, Calif., November 03, 2022--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), a leading consumer-focused...</p>\n\n<a href=\"https://finance.yahoo.com/news/report-goodrx-shows-positive-impact-110000434.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-03 19:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/report-goodrx-shows-positive-impact-110000434.html><strong>Business Wire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Analysis shows greater pharmacist prescribing authority dramatically improves patient access\nSANTA MONICA, Calif., November 03, 2022--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), a leading consumer-focused...</p>\n\n<a href=\"https://finance.yahoo.com/news/report-goodrx-shows-positive-impact-110000434.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PW","symbol_name":"Power REIT","start_time":0,"source_url":"https://finance.yahoo.com/news/report-goodrx-shows-positive-impact-110000434.html","article_id":"2280759672","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/t4NpyJ6yFG_Wieah4aUzGA--~B/aD0xMDI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a74e7f0783b8340941d5d8dfc940b160"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2280759672","pubTimestamp":1667473200,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Analysis shows greater pharmacist prescribing authority dramatically improves patient access\nSANTA M","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PW":"Power REIT","BK4084":"特种房地产投资信托","BK4167":"医疗保健技术","GDRX":"GoodRx Holdings, Inc.","BK4017":"黄金","NGD":"New Gold","BK4570":"地缘局势概念股"},"translate_title":"来自GoodRx的新报告显示赋予药剂师开处方的权力的积极影响","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NGD":1,"PW":1,"GDRX":0.9},"content_text":"Analysis shows greater pharmacist prescribing authority dramatically improves patient access\nSANTA MONICA, Calif., November 03, 2022--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), a leading consumer-focused digital healthcare platform, today released a new report that indicates that policies that expand pharmacists’ prescribing and dispensing authority greatly improve access to critical medications. The average person sees their pharmacists nearly 12 times more frequently than their HCPs, creating an enormous opportunity to bridge current gaps in the healthcare system.\nGoodRx Research examined the annual fill rate index from 2014-2022 for PrEP (pre-exposure prophylaxis), \"the HIV prevention pill,\" comparing states that have enacted policies that allow pharmacists to prescribe and dispense the medication to those that have not. In states that empower pharmacists, PrEP fills were significantly higher.\nAccording to previous research, only 25% of those eligible for PrEP actually receive it, despite its strong efficacy. This lack of access, coupled with the ability to see the effect of state policies over multiple years, makes PrEP a valuable case study indicating that pharmacist prescribing power can improve access to prescription medications. A few states currently allow pharmacists to prescribe other medications, including birth control, smoking cessation medications, and medications for conditions such as asthma and diabetes.\n\"When access improves, as we saw with this study, so does adherence,\" said Tori Marsh, MPH, Director of Research at GoodRx. \"It’s exciting to think about what would be possible if more states enacted these policies. It’s good for patients, and it’s also good for providers who are suffering high rates of burnout and will benefit from their patients having additional ways to receive medications.\"\nKey takeaways include:\n\nExpanding pharmacist prescriber authority for HIV PrEP medications significantly increased PrEP use.\nPrEP fills grew 24% after 1 year and 110% after 2 years in states that passed pharmacist prescriber policies for PrEP, including Colorado, California, Maine, Nevada, Oregon, and Virginia.\nOver 37 million people live in an under-resourced area. Expanding pharmacist prescriber authority in these areas could boost access to healthcare.\n\nGoodRx Research also mapped all U.S. counties that have sufficient pharmacy access but lack access to primary care providers and/or low-cost health clinics. Over 37 million people live in an under-resourced area where pharmacist prescriber authority could expand access to healthcare and lead to better health outcomes.\nTo learn more, please find the report here.\nAbout GoodRx\nGoodRx is a leading consumer-focused digital healthcare platform. Our technology delivers strong savings, trusted information and access to care to make healthcare affordable and convenient for all Americans. Since 2011, we have helped consumers save over $40 billion and are one of the most downloaded medical apps over the past decade.\nForward-Looking Statements\nThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the benefits of policies that expand pharmacists’ prescribing authority. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to our acquisition strategy, the integration of acquired business and the important factors discussed under the caption \"Risk Factors\" in GoodRx’s Annual Report on Form 10-K for the year ended December 31, 2021, and our other filings with the SEC. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20221103005555/en/\nContacts\nGoodRxLauren Casparislcasparis@goodrx.com","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2280759672"}